H.R. 3250 · 114th Congress
DXM Abuse Prevention Act of 2015
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
JohnsonSponsor20 cosponsors · 10 D, 10 R
D
Matsui
DL
D
Loebsack
PT
D
Tonko
MB
R
Burgess
BG
R
Guthrie
LB
R
Barletta
AK
R
Kinzinger
JB
D
Brownley
YC
D
Clarke
EN
D
Norton
JH
D
Huffman
JK
R
Katko
AH
D
Hastings
PO
R
Olson
RK
D
Kind
EP
R
Paulsen
RC
R
Costello
PM
R
Meehan
MD
D
DeSaulnier
MF
R
Fitzpatrick1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
What it does: CRS summary · Reported to House without amendment · Jul 8, 2016
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
DXM Abuse Prevention Act of 2015
(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.
(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: DXM Abuse Prevention Act of 2015
Latest action (Jul 8, 2016): Placed on the Union Calendar, Calendar No. 520.
Policy area: Health · Origin: House · Introduced: Jul 28, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.